Lupin receives tentative USFDA approval


Lupin has received tentative approval from the United States Food and Drug Administration (FDA) under the US President’s Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD) Tablets, 50 mg/300 mg/300 mg, and antiretroviral Fixed Dose Combination (FDC). This product would be manufactured at Lupin’s Nagpur facility in India, company said in the release..

Lupin was quoting at Rs 1,161.85, up Rs 0.85, or 0.07 percent on the BSE.

News Source:-Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button